Search Results 1861-1870 of 12736 for procedureare
This phase II trial evaluates how well AVD (doxorubicin hydrochloride, vinblastine, dacarbazine) in combination with brentuximab vedotin and nivolumab work in ...
Significant disparities in health care and birth outcomes are seen in the US during normal times. During COVID-19, limited access to health care resources, ...
Your gift holds great power – donate today! ... Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.
PARPs are proteins that help repair DNA mutations. PARP inhibitors, such as olaparib, can keep PARP from working, so tumor cells can't repair themselves, and ...
Wingo MT, Andersen CA, Bornstein SL, Huber JM, Szostek JH, Wieland ML. Update in Outpatient General Internal Medicine: Practice-Changing Evidence Published ...
Ridgeway JL, Gerdes EOW, Dodge A, Liedl CP, Juntunen MB, Sundt WJS, Glasgow A, Lampman MA, Fink AL, Severson SB, Lin G, Sampson RR, Peterson RP, Murley BM, ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The aim of this study is to evaluate the impact of liver International normalize ratio (INR) (in comparison to conventional INR) on MELD scores in chronic liver ...
Gritsch D, Mbonde AA, Khoury J. Hirayama Disease: A 15-Year-Old Male With Progressive Distal Right Upper Extremity Weakness. Neurologist.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.